Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia M Beasley

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Journal of Cancer Research and Clinical Oncology|December 30, 2025
Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|November 24, 2020
Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic EraRichard J Straker, Yun Song, James Sun, et al.
Annals of Surgical Oncology|July 22, 2022
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell CarcinomaAdrienne B Shannon, Richard J Straker, Michael J Carr, et al.
Annals of Surgical Oncology|April 23, 2021
Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell CarcinomaRichard J Straker, Michael J Carr, Andrew J Sinnamon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanomaGeorge Ansstas, Karam Khaddour, Sumedha Sudhaman, et al.
Annals of Surgical Oncology|April 7, 2025
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal MelanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|March 27, 2019
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter AnalysisJohn T Miura, Hidde M Kroon, Georgia M Beasley, et al.
Annals of Surgical Oncology|May 4, 2024
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 StudyJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|November 22, 2024
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
JAMA Surgery|October 22, 2025
Gene Expression Profile-Based Test to Predict Melanoma Sentinel Node Status: The MERLIN_001 StudyTina J Hieken, Michael E Egger, Christina V Angeles, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Journal of Cancer Research and Clinical Oncology|December 30, 2025
Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|November 24, 2020
Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic EraRichard J Straker, Yun Song, James Sun, et al.
Annals of Surgical Oncology|July 22, 2022
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell CarcinomaAdrienne B Shannon, Richard J Straker, Michael J Carr, et al.
Annals of Surgical Oncology|April 23, 2021
Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell CarcinomaRichard J Straker, Michael J Carr, Andrew J Sinnamon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2026
Longitudinal ctDNA monitoring for post-surgical disease surveillance in patients with stage I-IIIB melanomaGeorge Ansstas, Karam Khaddour, Sumedha Sudhaman, et al.
Annals of Surgical Oncology|April 7, 2025
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal MelanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|March 27, 2019
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter AnalysisJohn T Miura, Hidde M Kroon, Georgia M Beasley, et al.
Annals of Surgical Oncology|May 4, 2024
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 StudyJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology|November 22, 2024
Impact of Social Determinants of Health on Melanoma Nodal Surveillance in a Multi-institutional CohortKelsey B Montgomery, M Chandler McLeod, Danielle K DePalo, et al.
JAMA Surgery|October 22, 2025
Gene Expression Profile-Based Test to Predict Melanoma Sentinel Node Status: The MERLIN_001 StudyTina J Hieken, Michael E Egger, Christina V Angeles, et al.
Pageof 13